These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 90975)

  • 61. Platelet activation in hemolytic uremic syndrome.
    Karpman D; Manea M; Vaziri-Sani F; Ståhl AL; Kristoffersson AC
    Semin Thromb Hemost; 2006 Mar; 32(2):128-45. PubMed ID: 16575688
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Thrombotic thrombocytopenic purpura or Moschcowitz syndrome].
    Bellucci S; Tobelem G; Caen JP
    Nouv Rev Fr Hematol (1978); 1982; 24(3):197-203. PubMed ID: 6752882
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of the hemolytic uremic syndrome with plasma.
    Remuzzi G; Misiani R; Marchesi D; Livio M; Mecca G; de Gaetano G; Donati MD
    Clin Nephrol; 1979 Dec; 12(6):279-84. PubMed ID: 393447
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A proposed comprehensive pathophysiology of thrombotic thrombocytopenic purpura with implicit novel tests and therapies.
    Nalbandian RM; Henry RL
    Semin Thromb Hemost; 1980; 6(4):356-90. PubMed ID: 6452692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thrombotic thrombocytopenic purpura: from platelet aggregates to plasma.
    Marques MB; Mayfield CA; Blackall DP
    Am J Clin Pathol; 2004 Jun; 121 Suppl():S89-96. PubMed ID: 15298154
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the microangiopathic haemolytic anaemia's.
    Chandy M; Bhushan V
    J Assoc Physicians India; 1994 Jun; 42(6):470, 475-7. PubMed ID: 7852233
    [No Abstract]   [Full Text] [Related]  

  • 68. Frequency and significance of schistocytes in TTP/HUS patients at the discontinuation of plasma exchange therapy.
    Egan JA; Hay SN; Brecher ME
    J Clin Apher; 2004; 19(4):165-7. PubMed ID: 15597353
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thrombotic thrombocytopenic purpura without schistocytes on the peripheral blood smear.
    Daram SR; Philipneri M; Puri N; Bastani B
    South Med J; 2005 Mar; 98(3):392-5. PubMed ID: 15813170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Noncardiogenic pulmonary edema triggered by intravenous immunoglobulin in cancer-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
    Suassuna JH; da Costa MA; Faria RA; Melichar AC
    Nephron; 1997; 77(3):368-70. PubMed ID: 9375839
    [No Abstract]   [Full Text] [Related]  

  • 71. Successful treatment of thrombotic thrombocytopenic purpura by epoprostenol infusion.
    Payton CD; Belch JJ; Jones JM
    Lancet; 1985 Apr; 1(8434):927-8. PubMed ID: 2858768
    [No Abstract]   [Full Text] [Related]  

  • 72. Increased soluble thrombomodulin does not always indicate endothelial injury.
    Borawski J; Naumnik B; Myśliwiec M
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):87-9. PubMed ID: 11991246
    [No Abstract]   [Full Text] [Related]  

  • 73. Plasmapheresis for thrombocytopenia.
    Gandolfo GM; Afeltra A; Ferri GM
    Lancet; 1978 May; 1(8073):1095. PubMed ID: 77387
    [No Abstract]   [Full Text] [Related]  

  • 74. Parathyroid hormone inhibits human platelet function.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; Poletti E; Mecca G; de Gaetano G
    Lancet; 1981 Dec; 2(8259):1321-3. PubMed ID: 6118720
    [No Abstract]   [Full Text] [Related]  

  • 75. [Utility of plasmapheresis in intensive care].
    Salazar Ramirez C; Daga Ruiz D; Cota Delgado F; Fernández Aguirre C; Fernández Añon JM; Garcia Fernández JM
    Med Intensiva; 2010; 34(1):74-8. PubMed ID: 19837481
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Biologically active metabolites of unsaturated fatty acids and the function of contractile elements of the respiratory and vascular systems].
    Grodzińska L
    Folia Med Cracov; 1978; 20(2):211-30. PubMed ID: 363544
    [No Abstract]   [Full Text] [Related]  

  • 77. Plasma therapy at Klinikum Grosshadern: a 15-year retrospective.
    Samtleben W; Blumenstein M; Bosch T; Lysaght MJ; Schmidt B
    Artif Organs; 1996 May; 20(5):408-13. PubMed ID: 8725619
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood.
    Jørgensen KA; Pedersen RS
    Thromb Res; 1981 Feb; 21(3):311-5. PubMed ID: 7018005
    [No Abstract]   [Full Text] [Related]  

  • 79. Prostacyclin deficiency in haemolytic-uraemic syndrome.
    Webster J; Rees AJ; Lewis PJ; Hensby CN
    Br Med J; 1980 Jul; 281(6235):271. PubMed ID: 7000253
    [No Abstract]   [Full Text] [Related]  

  • 80. Platelets, endothelium, and renal disease.
    Lancet; 1979 Oct; 2(8148):890-1. PubMed ID: 90975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.